Verily aspires to create a world in which technology and life sciences are not distinct, but partners with a united mission. Formerly Google Life Sciences, Verily's mission is to bring together technology and life sciences to uncover new truths about health and disease. Verily's multidisciplinary teams have access to advanced research tools, large-scale computing power, and unique technical expertise. They work with partners from across the industry and many fields of research to develop new technology, launch studies and start companies. The company was founded in 2015 and is based in San Francisco, California, United States.

Imagine Eyes - Examine the retina beyond current limits Retinal diseases cause visual disability and blindness in over 400 million people worldwide. Imagine Eyes' mission is to enhance the diagnosis and management of these sight-threatening diseases, and improve visual health throughout the world. To do so, the company offers medical imaging devices that detect earlier signs of pathology at the back of the eye, deliver quicker readouts of treatment effectiveness, and enable more personalized retinal therapies. Imagine Eyes' products combine biophotonics imaging with adaptive optics, a breakthrough technology derived from the area of astrophysics. As a result, they deliver images with microscopic resolution, and doctors can examine patients' retinas with an unprecedented level of detail: the cellular level. With Imagine Eyes’ devices, the eye becomes a clear window to health. The company’s team collaborates with several medical centers in order to address clinical applications not only in retinal ophthalmology, but also in other disciplines including cardiology and neurology. Get in touch with Imagine Eyes' team via linkedin or this web page: https://www.imagine-eyes.com/contact/

Optos plc has the vision to be The retina company. We aim to be recognised as a leading provider of devices and solutions to eyecare professionals for improved patient care. Optos' core devices produce ultra widefield, high resolution digital images (optomaps) of approximately 82% of the retina, something no other device is capable of doing in any one image. Optos has a range of imaging devices that support different customer segments and patient levels: the P200 and 200Dx devices are concentrated on wellness screening carried out by optometrists and ophthalmologists in primary care; the P200C devices are designed to meet the need for more exacting clinical imaging capabilities and standards in secondary care within the ophthalmology market and at optometric practices that are clinically managing a patient base with advanced ocular disease; and the P200MA and 200Tx devices supports ophthalmologists and retinal specialists in the medical care market.

Physical Sciences provides contract research and development services in a wide diversity of technical areas to both government and commercial users. It offers adaptive infrared imaging spectroradiometers, compact adaptive optics retinal imagers, CR-doped ZNSE crystals, GASSCAN miniature diode laser-based ambient gas sensors, hand-held line scanning laser ophthalmoscopes, hybrid LSLO/spectral domain OCT imagers, lyoflux mass flux monitors, orientation-patterned gallium arsenide frequency converter devices, pharmaceutical process analytical technology sensors, quantum cascade laser sensors, RMLD portable standoff hazardous gas detectors, sideview microplates, tracking scanning laser ophthalmoscopes, tracking optical coherence tomography imagers, multi-wavelength gas sensors, tunable diode laser gas sensors, water vapor dials, and more. Physical Sciences Inc. was founded in 1973 and is headquartered in Andover, Massachusetts.

Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel.

Welch Allyn, Inc. develops and manufactures medical diagnostic and therapeutic devices. Its products include physical exam, patient monitoring, blood pressure measurement, thermometry, cardiopulmonary, medical lighting, animal health, and population health management technologies. It also offers batteries, lamps, cables and sensors, power supplies, cords and chargers, connectors and tubing, and probe covers and thermometry.\nThe company was founded by Francis Welch and William Noah Allyn in 1915 and is headquartered in Skaneateles Falls, NY.

Lumus (www.lumus-optical.com) products enable the fusion of the digital and physical world, allowing businesses and individuals to maximize the potential of augmented reality and smart eyewear today. Lumus has developed leading technology for see-through wearable displays, via its patented Light-guide Optical Element (LOE) platform to market leading producers of smart glasses and augmented reality eyewear. Lumus' technology enables a small natural looking form factor, wide field of view and true see-through performance.

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland.

TNO is an independent research organization with approximately 3,000 employees. They believe in joint creation of value in social and economic terms. They focus on transitions or changes in five social themes: Industry, Healthy Living, Defense & Safety, Environment and Energy. Targeted innovation, which is what TNO stands. They develop knowledge not about knowledge, but about practical application.

Remidio is engaged in designing & developing Smart, Innovative & Disruptive Imaging Technologies in Vision Care, using a product development approach called “Design Thinking”. As part of the Design Thinking process, Remidio takes into account different facets of a customer’s experience with a product, as part of its overall product design approach, with the intent of inventing a new customer experience with the product. Customers can be an amazing resource to glean insight and understanding, but they are generally not able to articulate their latent and anticipated needs. Remidio hence focuses on making quick functional prototypes, that can then be given to the customer to understand these latent needs while observing their use of the prototypes. Founded by professionals with a passion for product innovation, Remidio is currently focussed on creating game changing products and solutions in the ophthalmology space. We look at constraints posed by a developing nation context- infrastructure, skilled resources and affordable pricing as an opportunity to innovate. We bring to market very high quality products that are reliable and extremely simple to use.

Cylite is creating the next generation of imaging and metrology systems for ophthalmic, optometry, and related markets. The founding team have over 80 years experience in optics and have founded and grown a number of companies in the optical space which have generated over $850m in revenues. Cylite is based in Melbourne, Australia and first unveiled the unique Hyperparallel Coherence Tomography platform at Photonics West/BiOS in San Francisco, February 2015.

Shenzhen Skyworth New World Technology Co., Ltd., established on 2017-05-11, Business scope includes general business items:research and development,Sales of computer software and hardware,electronic product,communication device(Excluding wireless broadcasting and television transmitting and satellite ground receiving equipment),Industrial Automation Control Equipment;Computer hardware and software development and technical services;Software development and provision of technical services;Network technology development,Technical Services,technical consulting,technology transfer;Import and export;Equipment rental service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).,The licensing program is:none

Carl Zeiss Meditec AG engages in the development, manufacture and marketing of medical devices. It operates through the Ophthalmic Devices and Microsurgery business segments. The Ophthalmic Devices segment includes intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded on July 2002 and is headquartered in Jena, Germany.

Topcon, their core business is founded on the surveying instruments they have manufactured since their founding in 1932 and ophthalmic & medical equipment they introduced to the market following World War II. Since then, they have expanded their business domains through a combination of M&A and alliances, including construction machinery control technology since 1994, precision GPS receivers since 2000, precision agriculture since 2006, and mobile control technology since 2007. Today, the world is facing an increase in eye diseases due to global population aging, food shortages caused by global population increase, global infrastructure demands and a shortage of engineering personnel to meet that demand, and continued infrastructure deterioration. In the domains of healthcare, agriculture, and infrastructure, they embraces the slogan "Topcon for Human Life" as they work to expand their business by applying Topcon solutions towards resolving societal challenges.

Foshan Weget Electric Equipment Co., Ltd., established on 2011-03-25, Business scope includes research and development,design,manufacture,Sales:High and low voltage power electrical equipment,Industrial intelligent equipment,smart wearable device,communication equipment,electronic integration equipment,Security alarm equipment and system,Electronic Component,Hardware mold,Electric fittings and hardware products;Computer software and hardware sales;Software and Auxiliary Equipment,cloud computing software,System Integration Technology Development,technology transfer,Technical Advisory Services;Information Technology Support and Services;Domestic Trade;Engineering Technology Consulting Services;Engineering general contracting service;Mechanical and Electrical Engineering Installation Services;HR Consulting Services,Human resource outsourcing service(Does not include labor dispatch).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Eyeway Vision Ltd. is an Israeli company located in Or Yehuda. The firm develops augmented reality technology software. It was founded in 2014 by Raanan Cohen and Boris Greenberg. Raanan Cohen has been the CEO since then.\nThe company says this about itself: EyeWay Vision develops innovative wearable augmented reality systems that provide a truly immersive experience on the go. EyeWay Vision Ltd. was established in 2014 in Israel, and is backed by strategic investors including Samsung Next, Verizon Ventures, Horizons Ventures, ICONIQ Capital, and OurCrowd. EyeWay’s proprietary technology is protected by 17 patents published or pending.

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

Mimo Ltd, part of Styropack (UK) Ltd., is a company headquartered in Aberdare, UK, that manufactures and sells expanded polystyrene mouldings for the packaging industry. It was acquired by Styropack (UK) Ltd. from Royal Dutch Petroleum Co. on September 01, 1997.